Abstract

Automatic segmentation of brain tumors has the potential to enable volumetric measures and high-throughput analysis in the clinical setting. Reaching this potential seems almost achieved, considering the steady increase in segmentation accuracy. However, despite segmentation accuracy, the current methods still do not meet the robustness levels required for patient-centered clinical use. In this regard, uncertainty estimates are a promising direction to improve the robustness of automated segmentation systems. Different uncertainty estimation methods have been proposed, but little is known about their usefulness and limitations for brain tumor segmentation. In this study, we present an analysis of the most commonly used uncertainty estimation methods in regards to benefits and challenges for brain tumor segmentation. We evaluated their quality in terms of calibration, segmentation error localization, and segmentation failure detection. Our results show that the uncertainty methods are typically well-calibrated when evaluated at the dataset level. Evaluated at the subject level, we found notable miscalibrations and limited segmentation error localization (e.g., for correcting segmentations), which hinder the direct use of the voxel-wise uncertainties. Nevertheless, voxel-wise uncertainty showed value to detect failed segmentations when uncertainty estimates are aggregated at the subject level. Therefore, we suggest a careful usage of voxel-wise uncertainty measures and highlight the importance of developing solutions that address the subject-level requirements on calibration and segmentation error localization.

Highlights

  • Automated segmentation holds promise to improve the treatment of brain tumors by providing more reliable volumetric measures for treatment response assessment (Reuter et al, 2014) or by establishing new possibilities for high-throughput analysis, such as radiomics (Gillies et al, 2015)

  • While the calibration at the dataset level is good for all tumor regions, miscalibrations in the form of overconfidence and underconfidence are present at the subject level

  • We find an under-/overconfidence in 39%/25%, 30%/32%, and 21%/41% of the test subjects for the three tumor regions Whole tumor (WT), tumor core (TC), and enhancing tumor (ET)

Read more

Summary

Introduction

Automated segmentation holds promise to improve the treatment of brain tumors by providing more reliable volumetric measures for treatment response assessment (Reuter et al, 2014) or by establishing new possibilities for high-throughput analysis, such as radiomics (Gillies et al, 2015). The improvements in automated brain tumor segmentation methods led to a steady increase in performance. The amount of annotated data has increased, leading to larger and more diverse datasets. The available segmentation methods have evolved rapidly, especially with deep neural networks, which can leverage vast amounts of data.

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.